Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Tempest Therapeutics, Inc. (OVAS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Whiting Samuel (Chief Medical Officer) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 69,700 options to buy
@ $1.23, valued at
$85.7k
|
|
| 01/05/2023 |
4
| Dubensky Thomas W. (President) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 102,700 options to buy
@ $1.23, valued at
$126.3k
|
|
| 01/05/2023 |
4
| Brady Stephen R (CEO) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 177,300 options to buy
@ $1.23, valued at
$218.1k
|
|
| 01/05/2023 |
4
| Maestas Nicholas (VP of Strategy and Finance) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 38,425 options to buy
@ $1.23, valued at
$47.3k
|
|
| 01/05/2023 |
4
| Trojanowski Justin (Corporate Controller) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 20,300 options to buy
@ $1.23, valued at
$25k
|
|
| 10/04/2022 |
4
| Trojanowski Justin (Corporate Controller) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 2,500 options to buy
@ $1.85, valued at
$4.6k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Maestas Nicholas (VP of Strategy and Finance) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 51,270 options to buy
@ $2.35, valued at
$120.5k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Dubensky Thomas W. (President) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 87,801 options to buy
@ $2.35, valued at
$206.3k
|
|
| 06/22/2022 |
4
| Brady Stephen R (CEO) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 173,533 options to buy
@ $2.35, valued at
$407.8k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Woiwode Thomas (Director) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 3,500 options to buy
@ $2.08, valued at
$7.3k
|
|
| 06/22/2022 |
4
| Simantov Ronit (Director) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 3,500 options to buy
@ $2.08, valued at
$7.3k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Woiwode Thomas (10% Owner) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Bought 2,118,644 shares
@ $2.36, valued at
$5M
|
|
| 05/03/2022 |
4
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 4 on Tempest Therapeutics, Inc. |
| 01/11/2022 |
4
| Dubensky Thomas W. (President) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Bought 2,000 shares
@ $4.78, valued at
$9.6k
|
|
| 01/10/2022 |
4
| Whiting Samuel (Chief Medical Officer) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Bought 1,700 shares
@ $4.8048, valued at
$8.2k
|
|
| 01/06/2022 |
4
| Lorenzo Pierre (Corporate Controller) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 6,500 options to buy
@ $5.45, valued at
$35.4k
|
|
| 01/06/2022 |
4
| Maestas Nicholas (VP of Strategy and Finance) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 19,500 options to buy
@ $5.45, valued at
$106.3k
|
|
| 01/06/2022 |
4
| Whiting Samuel (Chief Medical Officer) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 29,000 options to buy
@ $5.45, valued at
$158.1k
|
|
| 01/06/2022 |
4
| Brady Stephen R (CEO) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 94,500 options to buy
@ $5.45, valued at
$515k
|
|
| 01/06/2022 |
4
| Dubensky Thomas W. (President) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 53,100 options to buy
@ $5.45, valued at
$289.4k
|
|
| 09/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Simantov Ronit (Director) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 6,635 options to buy
@ $13.6, valued at
$90.2k
|
|
| 07/14/2021 |
4
| Maestas Nicholas (VP of Strategy and Finance) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 23,225 options to buy
@ $24.19, valued at
$561.8k
|
|
| 07/06/2021 |
4
| Xu Stella (Director) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 6,635 options to buy
@ $11.07, valued at
$73.4k
|
|
| 07/06/2021 |
4
| Woiwode Thomas (10% Owner) has filed a Form 4 on Tempest Therapeutics, Inc.|
Txns:
| Granted 6,635 options to buy
@ $11.07, valued at
$73.4k
|
|
|
|
|